Efficacy of Lactobacillus rhamnosus GG in treatment of acute pediatric diarrhea: A systematic review with meta-analysis

Figure 1 Lactobacillus GG vs control with regard to the duration of diarrhea (hours). A: High dose and low dose; B: The duration of diarrhea before Lactobacillus rhamnosus GG participants’ enrollment: ≤2 d (>1 d), ≤3 d (>2 d), and ≤4 d (>3 d); C: Geography of the clinical trials: Asia, Europe, and other continents. LGG: Lactobacillus rhamnosus GG; CI: Confidence interval; SD: Standard deviation.

Figure 2 Lactobacillus GG vs control with regard to mean duration of diarrhea (hours) in children with rotavirus diarrhea. LGG: Lactobacillus rhamnosus GG; CI: Confidence interval; SD: Standard deviation.

Figure 3 Lactobacillus GG vs control with regard to the presence of diarrhea. A: Diarrhea lasting > 3 d; B: Diarrhea lasting > 4 d. LGG: Lactobacillus rhamnosus GG; CI: Confidence interval.

Figure 4 Lactobacillus GG vs control with regard to stool number and consistency. A: The average stool number per day (high dose and low dose); B: Stool frequency on day 2; C: Stool frequency on day 3; D: The mean time to improvement in stool consistency. LGG: Lactobacillus rhamnosus GG; CI: Confidence interval; SD: Standard deviation.

Figure 5 Lactobacillus GG vs control. A: The duration of hospital stay (hours); B: The hospital stay duration of rotavirus-positive children (hours). LGG: Lactobacillus rhamnosus GG; CI: Confidence interval; SD: Standard deviation.

Figure 6 Lactobacillus GG vs control with regard to vomiting. A: The number of participants with vomiting [number (%)]; B: The duration of vomiting (hours). LGG: Lactobacillus rhamnosus GG; CI: Confidence interval; SD: Standard deviation.